Review ArticleReview
Open Access

Circadian-driven transcriptional programs govern metastatic progression

Jie Wang, Hao Pan, Xuan Wang, Yuru Ren, Yiwen Huang, Yizhou Liu, Hejin Lai, Zhimin Fei, Ning Pu and Yu Wang
Cancer Biology & Medicine September 2026, 23 (9) 1213-1229; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0491

References

  1. 1.↵
    2. Pundir M,
    3. Papagerakis S,
    4. De Rosa MC,
    5. Chronis N,
    6. Kurabayashi K,
    7. Abdulmawjood S, et al.
    Emerging biotechnologies for evaluating disruption of stress, sleep, and circadian rhythm mechanism using aptamer-based detection of salivary biomarkers. Biotechnol Adv. 2022; 59: 107961.
  2. 2.↵
    2. Gerhart-Hines Z,
    3. Lazar MA.
    Rev-erbα and the circadian transcriptional regulation of metabolism. Diabetes Obes Metab. 2015; 17: 12–6.
    OpenUrlPubMed
  3. 3.↵
    2. Mohawk JA,
    3. Green CB,
    4. Takahashi JS.
    Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. 2012; 35: 445–62.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    2. Diamantopoulou Z,
    3. Castro-Giner F,
    4. Schwab FD,
    5. Foerster C,
    6. Saini M,
    7. Budinjas S, et al.
    The metastatic spread of breast cancer accelerates during sleep. Nature. 2022; 607: 156–62.
    OpenUrlCrossRefPubMed
  5. 5.↵
    2. Numata M,
    3. Hirano A,
    4. Yamamoto Y,
    5. Yasuda M,
    6. Miura N,
    7. Sayama K, et al.
    Metastasis of breast cancer promoted by circadian rhythm disruption due to light/dark shift and its prevention by dietary quercetin in mice. J Circadian Rhythms. 2021; 19: 2.
    OpenUrlPubMed
  6. 6.↵
    2. Wang Y,
    3. Sun N,
    4. Lu C,
    5. Bei Y,
    6. Qian R,
    7. Hua L.
    Upregulation of circadian gene ‘hClock’ contribution to metastasis of colorectal cancer. Int J Oncol. 2017; 50: 2191–9.
    OpenUrlPubMed
  7. 7.↵
    2. Liu K,
    3. Cui JJ,
    4. Zhan Y,
    5. Ouyang QY,
    6. Lu QS,
    7. Yang DH, et al.
    Reprogramming the tumor microenvironment by genome editing for precision cancer therapy. Mol Cancer. 2022; 21: 98.
    OpenUrlPubMed
  8. 8.↵
    2. Bose S,
    3. Saha P,
    4. Chatterjee B,
    5. Srivastava AK.
    Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy. Semin Cancer Biol. 2022; 86: 568–79.
    OpenUrlPubMed
  9. 9.↵
    2. Quail DF,
    3. Joyce JA.
    Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19: 1423–37.
    OpenUrlCrossRefPubMed
  10. 10.↵
    2. Singleton DC,
    3. Macann A,
    4. Wilson WR.
    Therapeutic targeting of the hypoxic tumour microenvironment. Nat Rev Clin Oncol. 2021; 18: 751–72.
    OpenUrlCrossRefPubMed
  11. 11.↵
    2. Wang Y,
    3. Guo H,
    4. He F.
    Circadian disruption: from mouse models to molecular mechanisms and cancer therapeutic targets. Cancer Metastasis Rev. 2023; 42: 297–322.
    OpenUrlPubMed
  12. 12.↵
    2. Wang Y,
    3. Narasimamurthy R,
    4. Qu M,
    5. Shi N,
    6. Guo H,
    7. Xue Y, et al.
    Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis. Nat Cancer. 2024; 5: 546–56.
    OpenUrlPubMed
  13. 13.↵
    2. Touitou Y,
    3. Reinberg A,
    4. Touitou D.
    Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: health impacts and mechanisms of circadian disruption. Life Sci. 2017; 173: 94–106.
    OpenUrlCrossRefPubMed
  14. 14.↵
    2. Xiao Q,
    3. James P,
    4. Breheny P,
    5. Jia P,
    6. Park Y,
    7. Zhang D, et al.
    Outdoor light at night and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Int J Cancer. 2020; 147: 2363–72.
    OpenUrlPubMed
  15. 15.↵
    2. Clarke RB,
    3. Amini H,
    4. James P,
    5. von Euler-Chelpin M,
    6. Jørgensen JT,
    7. Mehta A, et al.
    Outdoor light at night and breast cancer incidence in the Danish Nurse Cohort. Environ Res. 2021; 194: 110631.
  16. 16.↵
    2. Kim TW,
    3. Jeong JH,
    4. Hong SC.
    The impact of sleep and circadian disturbance on hormones and metabolism. Int J Endocrinol. 2015; 2015: 591729.
  17. 17.↵
    2. Zeitzer JM,
    3. Nouriani B,
    4. Rissling MB,
    5. Sledge GW,
    6. Kaplan KA,
    7. Aasly L, et al.
    Aberrant nocturnal cortisol and disease progression in women with breast cancer. Breast Cancer Res Treat. 2016; 158: 43–50.
    OpenUrlPubMed
  18. 18.↵
    2. Starreveld DEJ,
    3. Habers GEA,
    4. Valdimarsdottir HB,
    5. Kessels R,
    6. Daniëls LA,
    7. van Leeuwen FE, et al.
    Cancer-related fatigue in relation to chronotype and sleep quality in (non-)Hodgkin lymphoma survivors. J Biol Rhythms. 2021; 36: 71–83.
    OpenUrlPubMed
  19. 19.↵
    2. Cash E,
    3. Duck CR,
    4. Brinkman C,
    5. Rebholz W,
    6. Albert C,
    7. Worthen M, et al.
    Depressive symptoms and actigraphy-measured circadian disruption predict head and neck cancer survival. Psychooncology. 2018; 27: 2500–7.
    OpenUrlPubMed
  20. 20.↵
    2. Zhang J,
    3. Lv H,
    4. Ji M,
    5. Wang Z,
    6. Wu W.
    Low circadian clock genes expression in cancers: a meta-analysis of its association with clinicopathological features and prognosis. PLoS One. 2020; 15: e0233508.
  21. 21.↵
    2. Kuo SJ,
    3. Chen ST,
    4. Yeh KT,
    5. Hou MF,
    6. Chang YS,
    7. Hsu NC, et al.
    Disturbance of circadian gene expression in breast cancer. Virchows Arch. 2009; 454: 467–74.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    2. Cadenas C,
    3. van de Sandt L,
    4. Edlund K,
    5. Lohr M,
    6. Hellwig B,
    7. Marchan R, et al.
    Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014; 13: 3282–91.
    OpenUrlCrossRefPubMed
  23. 23.↵
    2. Yi H,
    3. Liao ZW,
    4. Chen JJ,
    5. Shi XY,
    6. Chen GL,
    7. Wu GT, et al.
    Genome variation in colorectal cancer patient with liver metastasis measured by whole-exome sequencing. J Gastrointest Oncol. 2021; 12: 507–15.
    OpenUrlPubMed
  24. 24.↵
    2. Oshima T,
    3. Takenoshita S,
    4. Akaike M,
    5. Kunisaki C,
    6. Fujii S,
    7. Nozaki A, et al.
    Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep. 2011; 25: 1439–46.
    OpenUrlPubMed
  25. 25.↵
    2. Mazzoccoli G,
    3. Pazienza V,
    4. Panza A,
    5. Valvano MR,
    6. Benegiamo G,
    7. Vinciguerra M, et al.
    ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol. 2012; 138: 501–11.
    OpenUrlCrossRefPubMed
  26. 26.↵
    2. He QY,
    3. Jin F,
    4. Li YY,
    5. Wu WL,
    6. Long JH,
    7. Luo XL, et al.
    Prognostic significance of downregulated BMAL1 and upregulated Ki-67 proteins in nasopharyngeal carcinoma. Chronobiol Int. 2018; 35: 348–57.
    OpenUrlPubMed
  27. 27.↵
    2. Cai YD,
    3. Chiu JC.
    Timeless in animal circadian clocks and beyond. FEBS J. 2022; 289: 6559–75.
    OpenUrlCrossRefPubMed
  28. 28.↵
    2. Wang X,
    3. Wang N,
    4. Wei X,
    5. Yu H,
    6. Wang Z.
    REV-ERBα reduction is associated with clinicopathological features and prognosis in human gastric cancer. Oncol Lett. 2018; 16: 1499–506.
    OpenUrlPubMed
  29. 29.↵
    2. Chen J,
    3. Liu A,
    4. Lin Z,
    5. Wang B,
    6. Chai X,
    7. Chen S, et al.
    Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling. Cancer Lett. 2020; 482: 56–71.
    OpenUrlPubMed
  30. 30.↵
    2. Wang Y,
    3. Ding Y,
    4. Guo N,
    5. Wang S.
    MDSCs: key criminals of tumor pre-metastatic niche formation. Front Immunol. 2019; 10: 172.
    OpenUrlCrossRefPubMed
  31. 31.↵
    2. Scheiermann C,
    3. Gibbs J,
    4. Ince L,
    5. Loudon A.
    Clocking in to immunity. Nat Rev Immunol. 2018; 18: 423–37.
    OpenUrlCrossRefPubMed
  32. 32.↵
    2. Perfilyeva YV,
    3. Abdolla N,
    4. Ostapchuk YO,
    5. Tleulieva R,
    6. Krasnoshtanov VC,
    7. Belyaev NN.
    Expansion of CD11b+Ly6Ghigh and CD11b+CD49d+ myeloid cells with suppressive potential in mice with chronic inflammation and light-at-night-induced circadian disruption. Inflamm Res. 2017; 66: 711–24.
    OpenUrlPubMed
  33. 33.↵
    2. Hadadi E,
    3. Taylor W,
    4. Li XM,
    5. Aslan Y,
    6. Villote M,
    7. Rivière J, et al.
    Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat Commun. 2020; 11: 3193.
    OpenUrlCrossRefPubMed
  34. 34.↵
    2. Zeng X,
    3. Liang C,
    4. Yao J.
    Chronic shift-lag promotes NK cell ageing and impairs immunosurveillance in mice by decreasing the expression of CD122. J Cell Mol Med. 2020; 24: 14583–95.
    OpenUrlPubMed
  35. 35.↵
    2. Logan RW,
    3. Zhang C,
    4. Murugan S,
    5. O’Connell S,
    6. Levitt D,
    7. Rosenwasser AM, et al.
    Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. J Immunol. 2012; 188: 2583–91.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    2. Tian R,
    3. Li Y,
    4. Shu M.
    Circadian regulation patterns with distinct immune landscapes in gliomas aid in the development of a risk model to predict prognosis and therapeutic response. Front Immunol. 2021; 12: 797450.
  37. 37.↵
    2. de Assis LVM,
    3. Kinker GS,
    4. Moraes MN,
    5. Markus RP,
    6. Fernandes PA,
    7. Castrucci AML.
    Expression of the circadian clock gene BMAL1 positively correlates with antitumor immunity and patient survival in metastatic melanoma. Front Oncol. 2018; 8: 185.
    OpenUrlPubMed
  38. 38.↵
    2. Shaashua L,
    3. Mayer S,
    4. Lior C,
    5. Lavon H,
    6. Novoselsky A,
    7. Scherz-Shouval R.
    Stromal expression of the core clock gene period 2 is essential for tumor initiation and metastatic colonization. Front Cell Dev Biol. 2020; 8: 587697.
  39. 39.↵
    2. Lee IK,
    3. Song H,
    4. Kim H,
    5. Kim IS,
    6. Tran NL,
    7. Kim SH, et al.
    RORα regulates cholesterol metabolism of CD8+ T cells for anticancer immunity. Cancers. 2020; 12: 1733.
    OpenUrlPubMed
  40. 40.↵
    2. Park SC,
    3. Park IG,
    4. Kim H,
    5. Lee JM.
    N-terminal domain mediated regulation of RORα1 inhibits invasive growth in prostate cancer. Int J Mol Sci. 2019; 20: 1684.
    OpenUrlPubMed
  41. 41.↵
    2. Yu X,
    3. Rollins D,
    4. Ruhn KA,
    5. Stubblefield JJ,
    6. Green CB,
    7. Kashiwada M, et al.
    TH17 cell differentiation is regulated by the circadian clock. Science. 2013; 342: 727–30.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    2. Hu X,
    3. Liu X,
    4. Moisan J,
    5. Wang Y,
    6. Lesch CA,
    7. Spooner C, et al.
    Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology. 2016; 5: e1254854.
  43. 43.↵
    2. Teleanu RI,
    3. Chircov C,
    4. Grumezescu AM,
    5. Teleanu DM.
    Tumor angiogenesis and anti-angiogenic strategies for cancer treatment. J Clin Med. 2019; 9: 84.
    OpenUrlPubMed
  44. 44.↵
    2. Mastrullo V,
    3. Cathery W,
    4. Velliou E,
    5. Madeddu P,
    6. Campagnolo P.
    Angiogenesis in tissue engineering: as nature intended? Front Bioeng Biotechnol. 2020; 8: 188.
    OpenUrlPubMed
  45. 45.↵
    2. Takaguri A,
    3. Sasano J,
    4. Akihiro O,
    5. Satoh K.
    The role of circadian clock gene BMAL1 in vascular proliferation. Eur J Pharmacol. 2020; 872: 172924.
  46. 46.↵
    2. Haus E,
    3. Dumitriu L,
    4. Nicolau GY,
    5. Bologa S,
    6. Sackett-Lundeen L.
    Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer. Chronobiol Int. 2001; 18: 709–27.
    OpenUrlCrossRefPubMed
  47. 47.↵
    2. Yasuniwa Y,
    3. Izumi H,
    4. Wang KY,
    5. Shimajiri S,
    6. Sasaguri Y,
    7. Kawai K, et al.
    Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway. PLoS One. 2010; 5: e15330.
  48. 48.↵
    2. Wood PA,
    3. Du-Quiton J,
    4. You S,
    5. Hrushesky WJ.
    Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006; 5: 2023–33.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    2. Wang CY,
    3. Wen MS,
    4. Wang HW,
    5. Hsieh IC,
    6. Li Y,
    7. Liu PY, et al.
    Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation. 2008; 118: 2166–73.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    2. Miyazaki K,
    3. Wakabayashi M,
    4. Hara Y,
    5. Ishida N.
    Tumor growth suppression in vivo by overexpression of the circadian component, PER2. Genes Cells. 2010; 15: 351–8.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    2. Besnard S,
    3. Silvestre JS,
    4. Duriez M,
    5. Bakouche J,
    6. Lemaigre-Dubreuil Y,
    7. Mariani J, et al.
    Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha. Circ Res. 2001; 89: 1209–15.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    2. Xu L,
    3. Liu Y,
    4. Cheng Q,
    5. Shen Y,
    6. Yuan Y,
    7. Jiang X, et al.
    Bmal1 downregulation worsens critical limb ischemia by promoting inflammation and impairing angiogenesis. Front Cardiovasc Med. 2021; 8: 712903.
  53. 53.↵
    2. Pastushenko I,
    3. Blanpain C.
    EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019; 29: 212–26.
    OpenUrlCrossRefPubMed
  54. 54.↵
    2. Gwon DH,
    3. Lee WY,
    4. Shin N,
    5. Kim SI,
    6. Jeong K,
    7. Lee WH, et al.
    BMAL1 suppresses proliferation, migration, and invasion of U87MG cells by downregulating cyclin B1, phospho-AKT, and metalloproteinase-9. Int J Mol Sci. 2020; 21: 2352.
    OpenUrlPubMed
  55. 55.↵
    2. Jung CH,
    3. Kim EM,
    4. Park JK,
    5. Hwang SG,
    6. Moon SK,
    7. Kim WJ, et al.
    BMAL1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol Rep. 2013; 29: 2109–13.
    OpenUrlCrossRefPubMed
  56. 56.↵
    2. Zhu M,
    3. Tang H,
    4. Tang X,
    5. Ma X,
    6. Guo D,
    7. Chen F.
    BMAL1 suppresses ROS-induced endothelial-to-mesenchymal transition and atherosclerosis plaque progression via BMP signaling. Am J Transl Res. 2018; 10: 3150–61.
    OpenUrlPubMed
  57. 57.↵
    2. Li Y,
    3. Basti A,
    4. Yalçin M,
    5. Relógio A.
    Circadian dysregulation of the TGFβ/SMAD4 pathway modulates metastatic properties and cell fate decisions in pancreatic cancer cells. iScience. 2020; 23: 101551.
  58. 58.↵
    2. Wang J,
    3. Li S,
    4. Li X,
    5. Li B,
    6. Li Y,
    7. Xia K, et al.
    Circadian protein BMAL1 promotes breast cancer cell invasion and metastasis by up-regulating matrix metalloproteinase9 expression. Cancer Cell Int. 2019; 19: 182.
    OpenUrlPubMed
  59. 59.↵
    2. Ma TJ,
    3. Zhang ZW,
    4. Lu YL,
    5. Zhang YY,
    6. Tao DC,
    7. Liu YQ, et al.
    CLOCK and BMAL1 stabilize and activate RHOA to promote F-actin formation in cancer cells. Exp Mol Med. 2018; 50: 1–15.
    OpenUrlCrossRefPubMed
  60. 60.↵
    2. Hwang-Verslues WW,
    3. Chang PH,
    4. Jeng YM,
    5. Kuo WH,
    6. Chiang PH,
    7. Chang YC, et al.
    Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proc Natl Acad Sci U S A. 2013; 110: 12331–6.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    2. Wang D,
    3. Fu L,
    4. Sun H,
    5. Guo L,
    6. DuBois RN.
    Prostaglandin E2 promotes colorectal cancer stem cell expansion and metastasis in mice. Gastroenterology. 2015; 149: 1884–95.e4.
    OpenUrlCrossRefPubMed
  62. 62.
    2. Shibue T,
    3. Weinberg RA.
    EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017; 14: 611–29.
    OpenUrlCrossRefPubMed
  63. 63.↵
    2. Yang L,
    3. Shi P,
    4. Zhao G,
    5. Xu J,
    6. Peng W,
    7. Zhang J, et al.
    Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020; 5: 8.
    OpenUrlPubMed
  64. 64.↵
    2. Chen P,
    3. Hsu WH,
    4. Chang A,
    5. Tan Z,
    6. Lan Z,
    7. Zhou A, et al.
    Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment. Cancer Discov. 2020; 10: 371–81.
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    2. Xuan W,
    3. Hsu WH,
    4. Khan F,
    5. Dunterman M,
    6. Pang L,
    7. Wainwright DA, et al.
    Circadian regulator CLOCK drives immunosuppression in glioblastoma. Cancer Immunol Res. 2022; 10: 770–84.
    OpenUrlCrossRefPubMed
  66. 66.↵
    2. Puram RV,
    3. Kowalczyk MS,
    4. de Boer CG,
    5. Schneider RK,
    6. Miller PG,
    7. McConkey M, et al.
    Core circadian clock genes regulate leukemia stem cells in AML. Cell. 2016; 165: 303–16.
    OpenUrlCrossRefPubMed
  67. 67.↵
    2. Dong Z,
    3. Zhang G,
    4. Qu M,
    5. Gimple RC,
    6. Wu Q,
    7. Qiu Z, et al.
    Targeting glioblastoma stem cells through disruption of the circadian clock. Cancer Discov. 2019; 9: 1556–73.
    OpenUrlAbstract/FREE Full Text
  68. 68.↵
    2. De A,
    3. Beligala DH,
    4. Sharma VP,
    5. Burgos CA,
    6. Lee AM,
    7. Geusz ME.
    Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks. Clin Exp Metastasis. 2020; 37: 617–35.
    OpenUrlPubMed
  69. 69.↵
    2. Li Q,
    3. Xia D,
    4. Wang Z,
    5. Liu B,
    6. Zhang J,
    7. Peng P, et al.
    Circadian rhythm gene PER3 negatively regulates stemness of prostate cancer stem cells via WNT/β-catenin signaling in tumor microenvironment. Front Cell Dev Biol. 2021; 9: 656981.
  70. 70.↵
    2. Zeeshan R,
    3. Mutahir Z.
    Cancer metastasis – tricks of the trade. Bosn J Basic Med Sci. 2017; 17: 172–82.
    OpenUrlPubMed
  71. 71.↵
    2. Fu LQ,
    3. Du WL,
    4. Cai MH,
    5. Yao JY,
    6. Zhao YY,
    7. Mou XZ.
    The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol. 2020; 353: 104119.
  72. 72.↵
    2. Sharma VP,
    3. Tang B,
    4. Wang Y,
    5. Duran CL,
    6. Karagiannis GS,
    7. Xue EA, et al.
    Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination. Nat Commun. 2021; 12: 7300.
    OpenUrlCrossRefPubMed
  73. 73.↵
    2. Sun Z,
    3. Li L,
    4. Yan Z,
    5. Zhang L,
    6. Zang G,
    7. Qian Y, et al.
    Circadian rhythm disorders elevate macrophages cytokines release and promote multiple tissues/organs dysfunction in mice. Physiol Behav. 2022; 249: 113772.
  74. 74.↵
    2. Aiello I,
    3. Mul Fedele ML,
    4. Román F,
    5. Marpegan L,
    6. Caldart C,
    7. Chiesa JJ, et al.
    Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation. Sci Adv. 2020; 6: eaaz4530.
  75. 75.↵
    2. Curtis AM,
    3. Fagundes CT,
    4. Yang G,
    5. Palsson-McDermott EM,
    6. Wochal P,
    7. McGettrick AF, et al.
    Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1. Proc Natl Acad Sci U S A. 2015; 112: 7231–6.
    OpenUrlAbstract/FREE Full Text
  76. 76.↵
    2. Gowda P,
    3. Lathoria K,
    4. Sharma S,
    5. Patrick S,
    6. Umdor SB,
    7. Sen E.
    Rewiring of lactate-interleukin-1β autoregulatory loop with clock-Bmal1: a feed-forward circuit in glioma. Mol Cell Biol. 2021; 41: e0044920.
  77. 77.↵
    2. Alexander RK,
    3. Liou YH,
    4. Knudsen NH,
    5. Starost KA,
    6. Xu C,
    7. Hyde AL, et al.
    Bmal1 integrates mitochondrial metabolism and macrophage activation. Elife. 2020; 9: e54090.
  78. 78.↵
    2. Sato S,
    3. Sakurai T,
    4. Ogasawara J,
    5. Takahashi M,
    6. Izawa T,
    7. Imaizumi K, et al.
    A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression. J Immunol. 2014; 192: 407–17.
    OpenUrlAbstract/FREE Full Text
  79. 79.↵
    2. Hams E,
    3. Roberts J,
    4. Bermingham R,
    5. Fallon PG.
    Functions for retinoic acid-related orphan receptor alpha (RORα) in the activation of macrophages during lipopolysaccharide-induced septic shock. Front Immunol. 2021; 12: 647329.
  80. 80.↵
    2. Haemmerle M,
    3. Stone RL,
    4. Menter DG,
    5. Afshar-Kharghan V,
    6. Sood AK.
    The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018; 33: 965–83.
    OpenUrlCrossRefPubMed
  81. 81.↵
    2. Paiva B,
    3. Paino T,
    4. Sayagues JM,
    5. Garayoa M,
    6. San-Segundo L,
    7. Martín M, et al.
    Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. Blood. 2013; 122: 3591–8.
    OpenUrlAbstract/FREE Full Text
  82. 82.↵
    2. Zhu X,
    3. Suo Y,
    4. Fu Y,
    5. Zhang F,
    6. Ding N,
    7. Pang K, et al.
    In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells. Light Sci Appl. 2021; 10: 110.
    OpenUrlPubMed
  83. 83.↵
    2. Tracey CJ,
    3. Pan X,
    4. Catterson JH,
    5. Harmar AJ,
    6. Hussain MM,
    7. Hartley PS.
    Diurnal expression of the thrombopoietin gene is regulated by CLOCK. J Thromb Haemost. 2012; 10: 662–9.
    OpenUrlCrossRefPubMed
  84. 84.↵
    2. Moustafa A.
    Chronic exposure to continuous brightness or darkness modulates immune responses and ameliorates the antioxidant enzyme system in male rats. Front Vet Sci. 2021; 8: 621188.
  85. 85.↵
    2. Krüger-Genge A,
    3. Blocki A,
    4. Franke RP,
    5. Jung F.
    Vascular endothelial cell biology: an update. Int J Mol Sci. 2019; 20: 4411.
    OpenUrlCrossRefPubMed
  86. 86.↵
    2. Bain AR,
    3. Weil BR,
    4. Diehl KJ,
    5. Greiner JJ,
    6. Stauffer BL,
    7. DeSouza CA.
    Insufficient sleep is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation. Atherosclerosis. 2017; 265: 41–6.
    OpenUrlPubMed
  87. 87.↵
    2. McAlpine CS,
    3. Swirski FK.
    Circadian influence on metabolism and inflammation in atherosclerosis. Circ Res. 2016; 119: 131–41.
    OpenUrlAbstract/FREE Full Text
  88. 88.↵
    2. Gao Y,
    3. Meng D,
    4. Sun N,
    5. Zhu Z,
    6. Zhao R,
    7. Lu C, et al.
    Clock upregulates intercellular adhesion molecule-1 expression and promotes mononuclear cells adhesion to endothelial cells. Biochem Biophys Res Commun. 2014; 443: 586–91.
    OpenUrlCrossRefPubMed
  89. 89.↵
    2. He W,
    3. Holtkamp S,
    4. Hergenhan SM,
    5. Kraus K,
    6. de Juan A,
    7. Weber J, et al.
    Circadian expression of migratory factors establishes lineage-specific signatures that guide the homing of leukocyte subsets to tissues. Immunity. 2018; 49: 1175–90.e7.
    OpenUrlCrossRefPubMed
  90. 90.↵
    2. Takeda N,
    3. Maemura K.
    Circadian clock and the onset of cardiovascular events. Hypertens Res. 2016; 39: 383–90.
    OpenUrlCrossRefPubMed
  91. 91.↵
    2. Rodrigo GC,
    3. Denniff M.
    Time-of-day variation in vascular function. Exp Physiol. 2016; 101: 1030–4.
    OpenUrlPubMed
  92. 92.↵
    2. Zhang SL,
    3. Lahens NF,
    4. Yue Z,
    5. Arnold DM,
    6. Pakstis PP,
    7. Schwarz JE, et al.
    A circadian clock regulates efflux by the blood-brain barrier in mice and human cells. Nat Commun. 2021; 12: 617.
    OpenUrlCrossRefPubMed
  93. 93.↵
    2. Mastrullo V,
    3. van der Veen DR,
    4. Gupta P,
    5. Matos RS,
    6. Johnston JD,
    7. McVey JH, et al.
    Pericytes’ circadian clock affects endothelial cells’ synchronization and angiogenesis in a 3D tissue engineered scaffold. Front Pharmacol. 2022; 13: 867070.
  94. 94.↵
    2. Khalyfa A,
    3. Poroyko VA,
    4. Qiao Z,
    5. Gileles-Hillel A,
    6. Khalyfa AA,
    7. Akbarpour M, et al.
    Exosomes and metabolic function in mice exposed to alternating dark-light cycles mimicking night shift work schedules. Front Physiol. 2017; 8: 882.
    OpenUrlCrossRefPubMed
  95. 95.↵
    2. Yeung CC,
    3. Dondelinger F,
    4. Schoof EM,
    5. Georg B,
    6. Lu Y,
    7. Zheng Z, et al.
    Circadian regulation of protein cargo in extracellular vesicles. Sci Adv. 2022; 8: eabc9061.
  96. 96.↵
    2. Dong P,
    3. Wang Y,
    4. Liu Y,
    5. Zhu C,
    6. Lin J,
    7. Qian R, et al.
    BMAL1 induces colorectal cancer metastasis by stimulating exosome secretion. Mol Biol Rep. 2022; 49: 373–84.
    OpenUrlPubMed
  97. 97.↵
    2. Fekry B,
    3. Ugartemendia L,
    4. Esnaola NF,
    5. Goetzl L.
    Extracellular vesicles, circadian rhythms, and cancer: a comprehensive review with emphasis on hepatocellular carcinoma. Cancers. 2024; 16: 2552.
    OpenUrlPubMed
  98. 98.↵
    2. Pein M,
    3. Insua-Rodríguez J,
    4. Hongu T,
    5. Riedel A,
    6. Meier J,
    7. Wiedmann L, et al.
    Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs. Nat Commun. 2020; 11: 1494.
    OpenUrlCrossRefPubMed
  99. 99.↵
    2. Abbas T,
    3. Dutta A.
    p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009; 9: 400–14.
    OpenUrlCrossRefPubMedWeb of Science
  100. 100.↵
    2. Gery S,
    3. Komatsu N,
    4. Baldjyan L,
    5. Yu A,
    6. Koo D,
    7. Koeffler HP.
    The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006; 22: 375–82.
    OpenUrlCrossRefPubMedWeb of Science
  101. 101.↵
    2. Mir SE,
    3. De Witt Hamer PC,
    4. Krawczyk PM,
    5. Balaj L,
    6. Claes A,
    7. Niers JM, et al.
    In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell. 2010; 18: 244–57.
    OpenUrlCrossRefPubMedWeb of Science
  102. 102.↵
    2. Farshadi E,
    3. Yan J,
    4. Leclere P,
    5. Goldbeter A,
    6. Chaves I,
    7. van der Horst GTJ.
    The positive circadian regulators CLOCK and BMAL1 control G2M/M cell cycle transition through Cyclin B1. Cell Cycle. 2019; 18: 16–33.
    OpenUrlCrossRefPubMed
  103. 103.↵
    2. Kondratov RV,
    3. Antoch MP.
    Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol. 2007; 17: 311–7.
    OpenUrlCrossRefPubMedWeb of Science
  104. 104.↵
    2. Lee Y,
    3. Lahens NF,
    4. Zhang S,
    5. Bedont J,
    6. Field JM,
    7. Sehgal A.
    G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment. PLoS Biol. 2019; 17: e3000228.
  105. 105.↵
    2. Fu XJ,
    3. Li HX,
    4. Yang K,
    5. Chen D,
    6. Tang H.
    The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cells. Onco Targets Ther. 2016; 9: 2237–45.
    OpenUrlPubMed
  106. 106.↵
    2. Wang Q,
    3. Ao Y,
    4. Yang K,
    5. Tang H,
    6. Chen D.
    Circadian clock gene Per2 plays an important role in cell proliferation, apoptosis and cell cycle progression in human oral squamous cell carcinoma. Oncol Rep. 2016; 35: 3387–94.
    OpenUrlPubMed
  107. 107.↵
    2. Han Y,
    3. Meng F,
    4. Venter J,
    5. Wu N,
    6. Wan Y,
    7. Standeford H, et al.
    miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth. J Hepatol. 2016; 64: 1295–304.
    OpenUrlPubMed
  108. 108.↵
    2. Wang Y,
    3. Kojetin D,
    4. Burris TP.
    Anti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cells. Biochem Pharmacol. 2015; 96: 315–22.
    OpenUrlCrossRefPubMed
  109. 109.↵
    2. Goswami S,
    3. Walle T,
    4. Cornish AE,
    5. Basu S,
    6. Anandhan S,
    7. Fernandez I, et al.
    Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma. Nat Med. 2020; 26: 39–46.
    OpenUrlCrossRefPubMed
  110. 110.↵
    2. Pu H,
    3. Bailey LC,
    4. Bauer LG,
    5. Voronkov M,
    6. Baxter M,
    7. Huber KVM, et al.
    Pharmacological targeting of BMAL1 modulates circadian and immune pathways. Nat Chem Biol. 2025; 21: 736–45.
    OpenUrlCrossRefPubMed
  111. 111.↵
    2. Gul S,
    3. Akyel YK,
    4. Gul ZM,
    5. Isin S,
    6. Ozcan O,
    7. Korkmaz T, et al.
    Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice. Nat Commun. 2022; 13: 6742.
    OpenUrlPubMed
  112. 112.
    2. Liu JL,
    3. Wang CY,
    4. Cheng TY,
    5. Rixiati Y,
    6. Ji C,
    7. Deng M, et al.
    Circadian clock disruption suppresses PDL1+ intraepithelial B cells in experimental colitis and colitis-associated colorectal cancer. Cell Mol Gastroenterol Hepatol. 2021; 12: 251–76.
    OpenUrlPubMed
  113. 113.
    2. Zhang W,
    3. He W,
    4. Shi Y,
    5. Zhao J,
    6. Liu S,
    7. Zhang F, et al.
    Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma. Int J Oncol. 2017; 50: 173–84.
    OpenUrlPubMed
  114. 114.
    2. Huisman SA,
    3. Ahmadi AR,
    4. JN IJ,
    5. Verhoef C,
    6. van der Horst GT,
    7. de Bruin RW.
    Disruption of clock gene expression in human colorectal liver metastases. Tumour Biol. 2016; 37: 13973–81.
    OpenUrlPubMed
  115. 115.
    2. Wang X,
    3. Yan D,
    4. Teng M,
    5. Fan J,
    6. Zhou C,
    7. Li D, et al.
    Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann Surg Oncol. 2012; 19: 3081–8.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords